InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MUM | MUM relisting tomorrow as IHL | 02/08/17 | 1 | 1.0K | |||
|
|||||||
MUM | Ann: Alistiar Pty Ltd becomes a Substantial Holder-MUM.AX | 28/10/16 | 0 | 477 | |||
|
|||||||
MUM | Ann: Appendix 3B-MUM.AX | 21/10/16 | 0 | 408 | |||
|
|||||||
MUM | Ann: Final Directors Interest Notice - Fennell-MUM.AX | 21/10/16 | 0 | 403 | |||
|
|||||||
MUM | Ann: Final Directors Interest Notice - Leavy-MUM.AX | 21/10/16 | 0 | 375 | |||
|
|||||||
MUM | Ann: Initial Directors Interest Notice - Weston-MUM.AX | 21/10/16 | 0 | 309 | |||
|
|||||||
MUM | Ann: Initial Directors Interest Notice - Smith-MUM.AX | 21/10/16 | 0 | 234 | |||
|
|||||||
MUM | Ann: Initial Directors Interest Notice - Worsfold-MUM.AX | 21/10/16 | 0 | 256 | |||
|
See All Discussions